Skandinaviska Enskilda Banken (SEB)
IMCR icon

Skandinaviska Enskilda Banken (SEB)’s Immunocore IMCR Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,918
Closed -$248K – 840
2025
Q2 		$248K Buy
+7,918
New +$246K ﹤0.01% 741

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IMCR Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Immunocore (IMCR) in Q3 2025, closing a stake of 7,918 shares — an estimated $248K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IMCR in Q2 2025 and held it in 1 quarter. The position peaked at $248K in Q2 2025. 132 funds tracked by Wall St. Rank hold IMCR as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Immunocore position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 7,918 Immunocore shares in Q3 2025, an estimated $248K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Immunocore in Q2 2025 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Immunocore position peaked at $248K in Q2 2025.
  • 132 funds tracked by Wall St. Rank held Immunocore as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.